Citius Pharmaceuticals CTXR
NASDAQ CTXR
$0.59 +0.01 (+1.86%)
As of: Sep 10, 2026 · 11:40 AM EDT

Citius Pharmaceuticals (CTXR) Receivables - Net (2025 - 2026)

Citius Pharmaceuticals' (CTXR) quarterly Receivables - Net came in at $686235.0 in Q2 2026, down 36.4% quarter-over-quarter from $1.1 million in Q1 2026.

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo
Analysis

Citius Pharmaceuticals (CTXR) Receivables - Net (2025 - 2026) Analysis & Trends

Citius Pharmaceuticals (CTXR) has reported Receivables - Net for 2 consecutive years, with $686235.0 the latest figure, recorded in Q2 2026.

Peer Set

Peer Comparison

All peers
# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 641.22 Bn 620.47 Bn 17.26 Bn
2 AbbVie 446.28 Bn 439.71 Bn 12.70 Bn
3 Merck 357.56 Bn 350.42 Bn 12.21 Bn
4 Novartis Ag 268.11 Bn 260.42 Bn 11.24 Bn
5 Pfizer 156.86 Bn 145.17 Bn 10.94 Bn
6 Sanofi 52.10 Bn 44.72 Bn 10.79 Bn
7 Revolution Medicines 43.01 Bn 43.01 Bn -
8 Incyte 24.82 Bn 20.28 Bn 1.57 Bn
9 United Therapeutics 21.39 Bn 18.73 Bn 683.80 Mn
10 Citius Pharmaceuticals 15.27 Mn 15.27 Mn 1.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 686,235.00
Mar 31, 2026 1.08 Mn
Dec 31, 2025 4.05 Mn